Persistent differences in dialysis patient outcomes among Medicare beneficiaries point to the importance of greater quality healthcare access for all. A study by Westat Insight’s Dominick Esposito, Ph.D., and coauthors Andrew Breck, Ph.D., Jeffrey Marr, and Marc Turenne, Ph.D., explored the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) and social risk factors to bring varying health outcomes to light.
Published in a recent issue of Medical Care, the article, The Role of Social Risk Factors in Dialysis Quality and Patient Outcomes Under a Medicare Quality Incentive Program, found no evidence of widening health differences in health outcomes in dialysis care or patient outcomes, which is a longstanding and well-publicized concern with value-based purchasing programs.
